We are so excited to be a Saving Lives at Birth Round 5 finalist! EGPAF's innovation— a model for national scale-up of the Pratt Pouch to expand infant nevirapine prophylaxis in Uganda--is a top contender addressing the problem of preventable newborn and maternal mortality in the developing world. Keep reading
The 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), will occur from July 19 through 22 in Vancouver, Canada. This gathering aims to explore new developments in HIV-related research and technology to inform a global response. EGPAF will be in attendance to share program implementation developments and gain new insights. Keep reading
Today, the global HIV/AIDS community is celebrating a major milestone—15 million people who are living with HIV are now on treatment—exceeding the target set out by Millennium Development Goal (MDG) 6: Halting and reversing the spread of HIV. Keep reading
Last week Ashley Rose Murphy shared her journey of growing-up HIV-positive and how she was inspired to become an advocate. Read below to learn about her work today and how you can get involved in the effort to create an AIDS-free future. Keep reading
Last week, Cuba became the first country to receive validation from the World Health Organization (WHO) for the elimination of mother-to-child transmission of HIV and syphilis. This blog serves as a guide through the WHO EMTCT validation process. Keep reading
Ashley Rose Murphy is 17 years old and has been living with HIV since birth. She uses her voice to educate people about HIV/AIDS and help combat fear and stigma many people living with HIV must face every day. She is sharing her story and her journey to becoming an advocate with EGPAF. Read her first installment below. Keep reading
Since 2000, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) remains one of the national beneficiaries of Alpha Epsilon Phi (AEPhi) sorority, with nationwide chapters that have generously raised more than $825,000 to support EGPAF’s efforts to end AIDS in children. Keep reading
Children living with HIV face many challenges when it comes to treatment, one being that often pediatric HIV medications are difficult for infants and young children to take due to their taste, making adherence difficult for parents and caregivers. Recent tentative approval by the U.S. Food and Drug Administration of a new pediatric ARV formulation of oral pellets of lopinavir and ritonavir (LPV/r) that can be mixed into a child’s food represents significant step in addressing this obstacle. Keep reading
Dinova Luhanga is a participant in a male study circle organized by Life Concern, a community-based organization in Malawi supported by the Elizabeth Glaser Pediatric AIDS Foundation. Traditionally, men are not very involved in issues of health, but study circles are an important tool for changing attitudes about what it means to be a successful man, husband, and father. Keep reading
